Cervical Erector Spinae Plane Block vs Cervical Plexus Block in Controlling Acute Postoperative Pain After Thyroidectomy
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to compare the efficacy and safety of cervical erector spinae plane block vs. cervical plexus block in controlling acute postoperative pain after thyroidectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2025
CompletedStudy Start
First participant enrolled
May 15, 2025
CompletedFirst Posted
Study publicly available on registry
May 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedDecember 29, 2025
December 1, 2025
7 months
May 8, 2025
December 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Total morphine consumption
Rescue analgesia of morphine will be given as 3 mg bolus if the numeric rating scale (NRS) \> 3 to be repeated after 30 min if pain persists until the NRS \< 4.
48 hours postoperatively
Secondary Outcomes (4)
Time to the 1st rescue analgesia
48 hours postoperatively
Intraoperative fentanyl consumption
Intraoperatively
Degree of pain
48 hours postoperatively
Incidence of adverse events
48 hours postoperatively
Study Arms (2)
ESPB group
EXPERIMENTALPatients will receive bilateral ultrasound-guided cervical erector spinae plane block using 15 ml of bupivacaine 0.25% on each side.
SCPB group
ACTIVE COMPARATORPatients will receive bilateral ultrasound-guided superficial cervical block using 15 mL of 0.25% plain bupivacaine on each side of the neck.
Interventions
Patients will receive bilateral ultrasound-guided cervical erector spinae plane block using 15 ml of bupivacaine 0.25% on each side.
Patients will receive bilateral ultrasound-guided superficial cervical block using 15 mL of 0.25% plain bupivacaine on each side of the neck.
Eligibility Criteria
You may qualify if:
- Age from 18 to 65 years.
- Both genders.
- American Society of Anesthesiologists (ASA) physical status I-II.
- Scheduled for either hemi- or total thyroidectomy.
You may not qualify if:
- Known allergy to local anesthetics.
- Allergy to all opioid medications.
- Pregnant patient.
- Previous neck surgery.
- Recent use of non-steroidal anti-inflammatory drugs (NSAIDs), opioids or steroid injection within 2 weeks.
- Those who cannot utilize the numeric rating scale (NRS) .
- Chronic opioid use.
- Coagulopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, 12613, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesia, Surgical ICU and Pain Management, Faculty of Medicine, National Cancer Institute, Cairo University, Egypt.
Study Record Dates
First Submitted
May 8, 2025
First Posted
May 16, 2025
Study Start
May 15, 2025
Primary Completion
November 30, 2025
Study Completion
November 30, 2025
Last Updated
December 29, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.